Speaker Profile
Ph.D., Director, Pfizer
Biography
Dr. Jadwiga Bienkowska is Sr. Director and Head of Computational Biology at Pfizer, Oncology Research and Development. ORD mission is development of breakthrough therapies for unmet needs of Cancer patients. Mission of the Computational Biology is to decode complex molecular data into data driven decisions to accelerate drug development from new targets discovery and MOA studies, translation of pre-clinical observation to patient selection and progression of new therapies through Phase I trials, and bedside to bench translation of insights from Phase III -IV trials clinical and biomarker data. Dr. Bienkowska has over 20 years of experience in Pharma and Biotech assuming roles of increasing responsibilities and leadership to leverage Data Science and unravel molecular mechanisms of disease, advance new therapies and deliver Precision Medicine to patients. Prior to joining Pfizer Dr. Bienkowska lead a computational biology research groups at BiogenIdec and EMD Serono focused on uncovering molecular drivers and new therapies for Immune and Neurological diseases and Cancer. Dr. Bienkowska holds PhD from the University of Chicago and completed postdoctoral training at Harvard Medical School.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Sharat Israni, UCSF
PMWC Award Ceremony
• Regina Barzilay, MIT
• Joe Petro, Microsoft (Dragon)
• Curtis P Langlotz, Stanford
Keynote
• Curtis P Langlotz, Stanford
From Foundation Models to Digital Twins: AI Reshaping Clinical Imaging
• Chair: Alexander Weir, Canon
• Regina Barzilay, MIT
• Joe Petro, Microsoft
• Curtis P Langlotz, Stanford
Fireside Chat
• Chair: Eric Horvitz, CSO, Microsoft
• Curtis P Langlotz, Stanford
Core AI Methods for Precision Medicine Foundation
• Chair: Sharat Israni, UCSF
• James Zou, Stanford
• Regina Barzilay, MIT
• Olivier Gevaert, Stanford
AI and Omics Foundation Models Powering Translational Research
• Chair: Janusz Dutkowski, Data4Cure
Radiomics & Radiogenomics: Harnessing Precision Imaging for Oncology
• Chair: Chris Hare, Canon Medical
• Ángel Alberich-Bayarri, Quibim
• Kevin Blyth, University of Glasgow
